where to give tirzepatide shot in leg injection site thigh: guide proper technique and placement Mounjaro injection sites: How and
Description
Those are the symptoms

Some weeks will be more, some less

Rosenstock J, Wysham C, Fras JP et al (2021) Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial

This dual action is one reason researchers believe tirzepatide can produce strong weight-loss results
Although a HR below unity suggests a possible protective association, the absolute risk reduction was very small, and this finding should be considered tentative and hypothesis-generating

Are there side effects
